Sabzevari Helen
- SEC CIK
- 0001724195
In the past year, 2 open-market sale filings worth $2.56M and no purchases.
Current role at each company
- PGEN Precigen, Inc.President and CEOas of Aug 25, 2026
- KNTE Kinnate Biopharma Inc.Directoras of Apr 5, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.56M
- 2 filings
- Net
- −$2.56M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sabzevari Helen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PGEN Precigen, Inc.
President and CEO11 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2021 (view filing) | Jul 19 | 1 day | Sabzevari HelenPresident and CEO | SSale | −12.5K | $5.43 | −$68.0K | −1.7%717.5K after | |
| Jan 4, 2022 (view filing) | Jan 3 | 1 day | Sabzevari HelenPresident and CEO | SSale | −3.85K | $3.67 | −$14.1K | −0.5%723.4K after | |
| Jan 6, 2022 (view filing) | Jan 5 | 1 day | Sabzevari HelenPresident and CEO | SSale | −6.96K | $3.59 | −$25.0K | −0.9%734.1K after | 2 lots |
| May 16, 2022 (view filing) | May 13 | 3 days | Sabzevari HelenPresident and CEO | SSale | −178.0K | $1.19 | −$211.8K | −16.6%897.1K after | |
| Jan 30, 2023 (view filing) | Jan 27 | 3 days | Sabzevari HelenPresident and CEO | PPurchase | +22.9K | $1.75 | +$40.0K | +2.5%937.6K after | |
| Aug 4, 2023 (view filing) | Aug 4 | Same day | Sabzevari HelenPresident and CEO | SSale | −52.9K | $1.10 | −$58.2K | −3.9%1.31M after | 10b5-1 |
| Aug 11, 2023 (view filing) | Aug 11 | Same day | Sabzevari HelenPresident and CEO | SSale | −41.4K | $1.44 | −$59.7K | −2.9%1.41M after | 10b5-1 |
| Aug 18, 2023 (view filing) | Aug 18 | Same day | Sabzevari HelenPresident and CEO | SSale | −55.9K | $1.66 | −$92.7K | −3.6%1.50M after | 10b5-1 |
| Aug 25, 2023 (view filing) | Aug 25 | Same day | Sabzevari HelenPresident and CEO | SSale | −77.0K | $1.53 | −$117.8K | −4.7%1.56M after | 10b5-1 |
| Jun 1, 2026 (view filing) | May 28 | 4 days | Sabzevari HelenPresident and CEO | SSale | −119.3K | $4.36 | −$519.9K | −3.1%3.77M after |